Putnam Investments LLC Acadia Pharmaceuticals Inc Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Putnam Investments LLC holds 102,262 shares of ACAD stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,262

Previous 85,403 19.74%

Holding current value

$1.76 Million

Previous $1.78 Million 79.93%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $350,330 - $535,610	16,859 Added 19.74%	102,262 $3.2 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $102,595 - $164,772	4,923 Added 6.12%	85,403 $1.78 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $981,794 - $1.41 Million	55,157 Added 217.81%	80,480 $1.93 Million
Q1 2023 May 22, 2023	SELL	$16.32 - $20.92 $17,413 - $22,321	-1,067 Reduced 4.04%	25,323 $476,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $198 - $260	-14 Reduced 0.05%	26,390 $420,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $372,560 - $482,401	26,404 New	26,404 $432,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $2.73 Million - $4.27 Million	-74,844 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $201,482 - $270,610	5,132 Added 7.36%	74,844 $3.63 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $207,022 - $306,576	6,541 Added 10.35%	69,712 $2.95 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $2.29 Million - $3.25 Million	63,171 New	63,171 $2.7 Million

Others Institutions Holding ACAD

# of Institutions

279

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.78B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Acadia Pharmaceuticals Inc Transaction History